Robert W. Baird reissued their neutral rating on shares of Molina Healthcare (NYSE:MOH - Free Report) in a research report report published on Tuesday morning, Marketbeat reports. Robert W. Baird currently has a $375.00 target price on the stock, up from their previous target price of $331.00.
A number of other equities research analysts have also recently issued reports on the company. Mizuho boosted their price objective on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Truist Financial raised their price objective on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, April 11th. UBS Group lowered their target price on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $350.00 price objective (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Finally, Stephens reiterated an "equal weight" rating and issued a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday, February 6th. Nine equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $359.42.
Get Our Latest Report on MOH
Molina Healthcare Price Performance
NYSE:MOH traded down $9.81 on Tuesday, hitting $322.57. The company had a trading volume of 1,443,462 shares, compared to its average volume of 660,969. Molina Healthcare has a 52 week low of $262.32 and a 52 week high of $370.99. The stock has a market capitalization of $17.64 billion, a price-to-earnings ratio of 15.79, a PEG ratio of 1.06 and a beta of 0.70. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The firm has a 50 day moving average of $314.72 and a two-hundred day moving average of $307.93.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, research analysts anticipate that Molina Healthcare will post 24.4 earnings per share for the current year.
Insider Activity
In other news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the transaction, the director now directly owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.26% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Molina Healthcare
Institutional investors have recently bought and sold shares of the stock. Tributary Capital Management LLC raised its holdings in Molina Healthcare by 76.1% in the fourth quarter. Tributary Capital Management LLC now owns 4,190 shares of the company's stock worth $1,219,000 after purchasing an additional 1,811 shares in the last quarter. Everence Capital Management Inc. bought a new position in shares of Molina Healthcare in the 4th quarter worth about $544,000. Smartleaf Asset Management LLC increased its stake in shares of Molina Healthcare by 123.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 347 shares of the company's stock worth $100,000 after acquiring an additional 192 shares in the last quarter. SYM FINANCIAL Corp purchased a new position in Molina Healthcare during the 4th quarter valued at about $249,000. Finally, Oddo BHF Asset Management Sas bought a new stake in Molina Healthcare during the third quarter worth about $2,947,000. 98.50% of the stock is owned by institutional investors.
About Molina Healthcare
(
Get Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
